Considerations for People with HIV in the Aging Population
Objectives
- Describe how the HIV lifespan has changed over the last 40 years
- Identify 3 important drug-drug interactions that may occur in the aging population among people with HIV
- Compare health risk factors associated with aging in people with HIV
- Summarize how health systems and clinicians can adapt to a population aging with HIV and comorbidities
Faculty
Caitlin S. Prather, PharmD, BCACP, AAHIVP, TTS
Clinical Pharmacy Specialist - Inova Juniper Program
Residency Program Director - PGY2 Ambulatory Care
2740 Prosperity Ave. Suite 200, Fairfax, VA 22031
T 703-321-2534 | E Caitlin.Prather@inova.org